Inventor

Mark Miglarese

Inventor

Phoenix, AZ, US

Overview

2005–2021

Patent span

Chemistry

Primary field (CPC C)

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary

C12NMicroorganisms or enzymes19%

A61KPreparations for medical, dental or toiletry purposes14%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%

G01NInvestigating or analysing materials by determining their chemical or physical properties14%

Y02ATechnologies for adaptation to climate change14%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%

C07DHeterocyclic compounds5%

C07HSugars5%

G06TImage data processing or generation, in general5%

PatentTitleYear

Assembled from patent assignee/location history and declaration credentials.

2005Patents assigned to BAYER PHARMACEUTICALS CORP (1)· patent assignee history

2005Based in Ivorytown, CT, US· patent location history

2020–2021Patents assigned to CARIS SCIENCE INC (4)· patent assignee history

2020Patents assigned to GENECENTRIC THERAPEUTICS INC (1)· patent assignee history

2020Patents assigned to UNIV NORTH CAROLINA CHAPEL HILL (1)· patent assignee history

2020–2021Based in Phoenix, AZ, US· patent location history

2020Based in Durham, NC, US· patent location history

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CARIS SCIENCE INC	4	2020–2021
BAYER PHARMACEUTICALS CORP	1	2005
GENECENTRIC THERAPEUTICS INC	1	2020
UNIV NORTH CAROLINA CHAPEL HILL	1	2020

Locations